Vision loss in patients with giant cell arteritis treated with tocilizumab

Juvenile Idiopathic ArthritisRheumatoid Arthritis

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Arthritis Res Ther

Unizony S, McCulley TJ, Spiera R, Pei J, Sidiropoulos PN, Best JH, Birchwood C, Pavlov A, Stone JH

doi: 10.1186/s13075-020-02377-8

EULAR ^® 2020

Giant Cell Arteritis

Further Publications Rheumatology

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

Arthritis Res Ther

de Boysson H, Le Besnerais M, Blaison F, Daumas A, Jarrot PA, Perrin F, Tieulié N, Maria A, Duffau P, Gombert B, Samson M, Espitia O, Lambert M, Mékinian A, Aouba A, French Study Group for Large Vessel Vasculitis (GEFA).

doi: 10.1186/s13075-021-02529-4

Further Publications Rheumatology

Patient perceptions of health-related quality of life in giant cell arteritis; international development of a disease-specific Patient-Reported Outcome Measure

Rheumatology (Oxford)

Robson JC, Almeida C, Dawson J, Bromhead A, Dures E, Guly C, Hoon E, Mackie S, Ndosi M, Pauling J, Hill C

doi: 10.1093/rheumatology/keab076

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review

JAMA.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B

doi: 10.1001/jama.2016.5444.

Further Publications Rheumatology

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Ann Rheum Dis

Adriawan IR, Atschekzei F, Dittrich-Breiholz O, Garantziotis P, Hirsch S, Risser LM, Kosanke M, Schmidt RE, Witte T, Sogkas G

doi: 10.1136/annrheumdis-2021-220955

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

Rheumatol Ther.

Schmidt WA, Dasgupta B, Luqmani R, Unizony SH, Blockmans D, Lai Z, Kurrasch RH, Lazic I, Brown K, Rao R

doi: 10.1007/s40744-020-00227-2.

Juvenile Idiopathic ArthritisRheumatoid Arthritis

Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial

Rheumatology (Oxford)

Nakaoka Y, Yanagawa M, Hata A, Yamashita K, Okada N, Yamakido S, Hayashi H, Jayne D

doi: 10.1093/rheumatology/keab684

COMMENTED

Melanoma and Skin Cancer

Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy

JAMA Dermatol.

Sun L, Chin RI, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT, Koyfman SA, Manyam BV

doi: 10.1001/jamadermatol.

Related content

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Giant Cell Arteritis

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

Patient perceptions of health-related quality of life in giant cell arteritis; international development of a disease-specific Patient-Reported Outcome Measure

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial

Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy